Endurant stent-graft for the treatment of abdominal aorta aneurysm
2012-08-15JiaXin
/Jia Xin
(贾鑫,Dept Vascul Surg,PLA Gen Hosp,Beijing 100853)…∥Chin J Gen Surg.-2011,26(11).-904 ~906
ObjectiveTo evaluate early results of Endurant stent-graft in the treatment of abdominal aortic aneurysms(AAAs).MethodsFrom July 2010 to June 2011,68 patients(57 men,11 women;mean age 74.3 years)were treated with Endurant stent-graft at our center.26 cases had hostile proximal neck in the anatomy.According to ASA classification,15 cases were class Ⅱ ;32 cases were classⅢ and 21 cases were classⅣ.ResultsIntraoperative immediate technical success was achieved in all cases.At completion angiography,a type Ⅱ endoleak was detected in 18(26%)of the 68 patients.The mean operation time was(96 ±29)min,the mean blood loss was(99 ± 68)ml,and the mean contrast usage was(122±65)ml.No intraoperative conversion to open surgery,stent migration,types Ⅰ/Ⅲ endoleak,other major complications,or death was encountered.49 patients(72%)had a postimplantation syndrome with fever,leukocytosis,and increase of C-reactive protein levels,which completely resolved within two weeks.The mean follow-up time was(8 ± 5)months.ConclusionEndurant stentgraft seems to be safe and effective in endovascular aneurysm repair,even in patients with hostile aortoiliac anatomy.8 refs
杂志排行
外科研究与新技术的其它文章
- Value of diffusion-weighted MR imaging and dynamic-contrast enhanced MRI in the diagnosis of breast cancer
- Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied to advanced pancreatic cancer
- Effect of decompression in different time on hemodynamics and oxygen metabolism of porcine model with severe acute pancreatitis combined intraabdominal hypertension
- Postoperative use of Sorafenib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria
- Combined liver-kidney transplantation and orthotopic liver transplantation in the treatment of severe hepatitis B
- HO-1 up-regulation decreases liver ischemia/reperfusion injury by inhibiting mast cells degranulation
